10-Q Filing

ACCELERATE DIAGNOSTICS, INC CIK: 727207 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001000096-13-000149`
Period End Date	20130930
Filing Date	20131108
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	axdx-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 68 Cash Flow Statement 50

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	45.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	55.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	41.47M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.77M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	25.33M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	25.33M	shares	Point-in-time
Investments	`AccruedInvestmentIncomeReceivable`	-	USD	Point-in-time
Investments	`AccruedInvestmentIncomeReceivable`	$10.96M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	41.47M	shares	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$106.24K	USD	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$763.90K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$115.00K	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	5,000.00	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$16.38K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.85M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	5,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$44.63M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$147.81K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.04M	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$319.28K	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$259.88K	USD	Point-in-time
Total Assets	`Assets`	$45.93M	USD	Point-in-time
Total Assets	`Assets`	$13.32M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$299.65K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.76K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$321.17K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$870.38K	USD	Point-in-time
Deferred revenue and income	`DeferredRevenue`	$78.03K	USD	Point-in-time
Deferred revenue and income	`DeferredRevenue`	$84.01K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$411.94K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.25M	USD	Point-in-time
Long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	-	USD	Point-in-time
Long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$526.67K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$938.61K	USD	Point-in-time
Common stock, $0.001 par value; 55,000,000 shares authorized (as of September 2013) and 45,000,000 shares authorized (as of December 31, 2012) ; 41,467,771 (2013) and 25,331,939 (2012) shares issued and outstanding	`CommonStockNoParValue`	$41.47K	USD	Point-in-time
Common stock, $0.001 par value; 55,000,000 shares authorized (as of September 2013) and 45,000,000 shares authorized (as of December 31, 2012) ; 41,467,771 (2013) and 25,331,939 (2012) shares issued and outstanding	`CommonStockNoParValue`	$25.33K	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized and none outstanding (as of September 30, 2013)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized and none outstanding (as of September 30, 2013)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$74.27M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$31.24M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.20M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-29.32M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities`	-	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities`	$10.91K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$44.99M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$12.07M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$45.93M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$13.32M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
OptiChem revenue	`LicensesRevenue`	$5.12K	USD	1 Quarter
OptiChem revenue	`LicensesRevenue`	$37.03K	USD	3 Qtrs
OptiChem revenue	`LicensesRevenue`	$12.80K	USD	1 Quarter
OptiChem revenue	`LicensesRevenue`	$35.85K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$12.80K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$35.85K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$37.03K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$5.12K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.00M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$200.09K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.65M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$402.85K	USD	3 Qtrs
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$2.92M	USD	3 Qtrs
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$1.05M	USD	1 Quarter
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$1.63M	USD	1 Quarter
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$2.80M	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$139.37K	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$19.21K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$57.69K	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$10.62K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$1.58K	USD	3 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$84.21K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$551.00	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$191.16K	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$10.16M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.81M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$1.84M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.34M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.80M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-10.13M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.84M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.30M	USD	3 Qtrs
Other expense	`OtherCostAndExpenseOperating`	$1.97M	USD	3 Qtrs
Other expense	`OtherCostAndExpenseOperating`	$8.95K	USD	1 Quarter
Other expense	`OtherCostAndExpenseOperating`	$10.43K	USD	3 Qtrs
Other expense	`OtherCostAndExpenseOperating`	$2.00M	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$12.99K	USD	3 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$10.51K	USD	3 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$4.40K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$9.01K	USD	1 Quarter
Total other income / (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$55.00	USD	1 Quarter
Total other income / (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.56K	USD	3 Qtrs
Total other income / (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.00M	USD	1 Quarter
Total other income / (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.96M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-10.12M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.84M	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	3 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	3 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	35.99M	shares	3 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	16.06M	shares	3 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	25.00M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	39.77M	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-10.12M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.84M	USD	1 Quarter
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	-	USD	3 Qtrs
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	$10.91K	USD	3 Qtrs
Net unrealized gain/(loss) on available-for-sale investments	`UnrealizedGainLossOnInvestments`	$10.91K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.26M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.11M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.84M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.79M	USD	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-10.12M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.84M	USD	1 Quarter
Depreciation	`Depreciation`	$191.16K	USD	3 Qtrs
Depreciation	`Depreciation`	$1.58K	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$139.37K	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$19.21K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$57.69K	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$10.62K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.61M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$509.47K	USD	3 Qtrs
Impairment of intangible assets	`AssetImpairmentCharges`	$9.20K	USD	3 Qtrs
Impairment of intangible assets	`AssetImpairmentCharges`	$2.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$593.86K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$657.66K	USD	3 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$30.87K	USD	3 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-98.62K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$66.08K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-292.89K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$800.92K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-549.21K	USD	3 Qtrs
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$532.64K	USD	3 Qtrs
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$-22.46K	USD	3 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$-109.37K	USD	3 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	-	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.25M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.00M	USD	3 Qtrs
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$1.09M	USD	3 Qtrs
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$114.31K	USD	3 Qtrs
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	$-10.95M	USD	3 Qtrs
Purchase of available-for-sale securities	`PaymentsToAcquireMarketableSecurities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-114.31K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.04M	USD	3 Qtrs
Sale of Common Stock and Warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$19.91M	USD	3 Qtrs
Sale of Common Stock and Warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$14.55M	USD	3 Qtrs
Exercise of Warrants and Options	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Exercise of Warrants and Options	`ProceedsFromStockOptionsExercised`	$20.51M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$40.43M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.55M	USD	3 Qtrs
Increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$13.18M	USD	3 Qtrs
Increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$21.38M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.45M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.77M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.45M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.77M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.